ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

I've never had dry or cracked heels until recently and I've tried everything I could find to get rid of them! This is all you ...

New NAD+ Patch, Injection, and Nasal Spray Now Available for Personalized Wellness and Longevity SolutionsVANCOUVER, British Columbia and LAS VEGAS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Hydreight ...